Introduction
============

As a disease of the chronic digestive system, chronic diarrhea is commonly manifested as changes in bowel habits, diarrhea and abdominal pain as well as abdominal distension in a few cases. The pathogenesis of the disease is mostly the intestinal flora imbalance and ectopia, endocrine dysfunction and mental stress. Besides, excessive mental stress often causes neuroendocrine dysfunction, with such manifestations as the secretion disorders of corticotropin-releasing hormone and adrenocorticotropic hormone ([@b1-etm-0-0-7977]), which lead to mental mania or apathy, delusion and depression in patients and induce the onset of depression in patients.

Increasingly more studies have revealed that inflammatory cytokines also exert crucial effects in the onset process of depression. Both in adequate and excessive secretions of collective anti-inflammatory cytokines are the most important mechanisms of chronic diarrhea. Excessively secreted inflammatory cytokines can induce depression, thus resulting in a variety of symptoms of depression such as sexual hypoactivity, reduced social activity, slow action and sleep disorders ([@b2-etm-0-0-7977]), and studies have manifested that the changes in the level of cytokines have a correlation with the occurrence of depression in patients ([@b3-etm-0-0-7977]). The present study aimed to observe the efficacy of electroacupuncture combined with probiotics in the treatment of patients with depression and chronic diarrhea and its influence on cytokines, and to investigate the correlations of cytokines with the occurrence and prognosis of the disease.

Patients and methods
====================

### Study subjects

A total of 104 patients with depression and chronic diarrhea admitted to The First Clinical Faculty, Guangxi University of Traditional Chinese Medicine (Nanning, China) from July 2014 to June 2018 were selected, and they were divided into the observation group (n=56) and the control group (n=48). The diagnostic criteria for depression were based on the 10th revision of the International Statistical Classification of Diseases and Related Health Problems ([@b4-etm-0-0-7977]) and the 3rd revision of the Chinese Classification of Mental Disorders. There were no statistically significant differences in age, sex, course of the disease and complication with other underlying diseases between the two groups of patients (p\>0.05).

The present study was approved by the Ethics Committee of The First Clinical Faculty, Guangxi University of Traditional Chinese Medicine. The signed informed consents were obtained from the patients or the guardians.

### Treatment methods

Patients in the control group took orally trimebutine maleate tablets (100 mg/time, 3 times/day) and meptintin (100 mg/day, and the dose was adjusted according to the patient\'s condition and side effects). Patients in the observation group were treated with electroacupuncture and oral probiotics, 50 mm acupuncture needles were used to acupuncture such acupoints as Baihui point, Sanyinjiao point and Yanglingquan point. After the air was obtained, the electroacupuncture machine was connected for electroacupuncture for 30 min each day. Additionally, the patients took viable *bifidobacterium* quadruple tablets (1.5 g/time, 3 times/day) with warm water after meals. Blood was drawn from the two groups of patients for scale evaluation before and after treatment.

### Scale assessment

The two groups of patients were scored by Hamilton Depression Rating Scale (HAM-D) before and after treatment. Criteria for chronic diarrhea: diarrhea ≥3 times/day, thin or watery stool and no obvious pus and blood accompanied with abdominal pain, abdominal distension and tenesmus and duration \>3 weeks ([@b5-etm-0-0-7977]).

### Detection methods

The venous blood of patients was taken at admission and at 3 weeks after treatment. After centrifugation at 6,000 × g, for 10 min at 4°C, the supernatant was taken, and the changes in the levels of serum inflammatory cytokines interleukins (ILs) and the tumor necrosis factor (TNF)-α), norepinephrine (NE) and brain-derived neurotrophic factor (BDNF) were detected by means of radioimmunoassay. Fecal flora culture: Approximately 5 g sterile feces of the patients were taken, diluted with normal saline, shaken, homogenized, inoculated on the selective medium and cultured in an incubator at 35°C for 24 h. Finally, the methylene blue chemical indicator was added and the bacterial colony formed was counted.

### Statistical analysis

Statistical analysis was carried out via SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Data were expressed as mean ± SD. The Students\' tests were used to for comparisons of HAM-D score, intestinal flora, inflammatory cytokines, NE level, BDNF level, treatment efficacy. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Comparison of the HAM-D score between the two groups of patients

At 3 weeks after treatment, the total HAM-D score of the two groups of patients was significantly reduced, but no statistical difference was found between them (p\>0.05), suggesting that both electroacupuncture and maprotiline markedly improve the depression symptoms of the patients, and the overall efficacy of them is identical. The univariate analysis demonstrated that the improvement degrees of sleep disorders and cognitive impairment in the observation group were evidently higher than those in the control group (p\<0.05) ([Table I](#tI-etm-0-0-7977){ref-type="table"}).

### Comparison of the intestinal flora between the two groups of patients

Compared with the intestinal flora in normal individuals, the enterobacteria were increased significantly, while *lactobacilli* and *enterococci* were decreased (not shown in results) in patients with chronic diarrhea. After the treatment, the enterobacteria were reduced, while *lactobacilli, enterococci* and other bacteria rose again in the both groups of patients. Among them, the elevated level of *lactobacilli* in the observation group was obviously higher than that in the control group, with a statistically significant difference (p\<0.05) ([Table II](#tII-etm-0-0-7977){ref-type="table"}).

### Effects of the cell inflammatory cytokines between the two groups of patients

Compared with those in normal patients, the serum inflammatory cytokines in the two groups before treatment were obviously increased before treatment. The levels of ILs and TNF-α in serum in the two groups of patients at 3 weeks after treatment returned to normal. There was no significant difference in the reduced level of inflammatory cytokines between the two groups (p\>0.05) ([Fig. 1A and B](#f1-etm-0-0-7977){ref-type="fig"}).

### Comparison of the NE level between the two groups of patients

Compared with the normal value, before treatment, the NE levels were significantly increased, while the 5-hydroxytryptamine (5-HT) levels were significantly decreased in the two groups of patients. At 3 weeks after treatment, the NE levels were decreased to normal, and the 5-HT levels also returned to normal in the two groups of patients. Among them, the level of 5-HT in the observation group was higher than that in the control group, showing a statistically significant difference (p\<0.05), but no significant difference in the NE level was found between the two groups (p\>0.05) ([Table III](#tIII-etm-0-0-7977){ref-type="table"}).

### Changes in the BDNF level between the two groups of patients

Before treatment, the levels of BDNF in the two groups were significantly lower than the normal value. After treatment, the levels of BDNF in the two groups were increased, and the increased level of BDNF in the observation group was higher than that in the control group (p\<0.05) ([Fig. 2](#f2-etm-0-0-7977){ref-type="fig"}).

### Comparison of the efficacy on chronic diarrhea between the two groups of patients

At 3 weeks after treatment, the total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (p\<0.05) ([Table IV](#tIV-etm-0-0-7977){ref-type="table"}).

Discussion
==========

The faster pace of modern society and the increased mental stress of people has led to an increased number of mental diseases, the most common of which is depression. Depression in patients is usually manifested in the form of sleep disorders, reduced or regressed social activities, reduced desires, weight loss, hyperalgesia and autism ([@b6-etm-0-0-7977]). Research results have shown that the occurrence of depression in patients is associated with the excessive secretion of cytokines ([@b7-etm-0-0-7977]). It has been confirmed that the levels of IL-6, TNF-α and IL-1 are elevated in the acute phase of depression in patients, and can reflect the severity of depression and partial depression in patients ([@b8-etm-0-0-7977]). After patients are administered antidepressant drugs, the levels of serum IL-6 and TNF-α markedly decline to normal, indicating that cytokines exert certain effects in the onset of depression ([@b9-etm-0-0-7977]). The excessive secretion of inflammatory cytokines during the onset of depression can lead to insufficient secretion of anti-inflammatory cytokines in patients, thus causing an anti-inflammatory/inflammatory imbalance. As a chemokine, IL-8 plays a vital role in the intestinal inflammation. Secreted by intestinal epithelial cells and macrophages, IL-8 can regulate the phagocytosis of neutrophils through activation and chemotaxis. The excessive secretion of IL-8 can induce the systolic dysfunction of smooth muscle of the intestinal nervous system and influence the local intestinal neuroimmunoendocrine network system, thus triggering the intestinal mucosal inflammation ([@b10-etm-0-0-7977]). In addition, the excessive secretion of TNF-α stimulates intestinal mucosal epithelial cells, promotes the proliferation of fibroblasts and causes the degradation of intestinal mucosa epithelial function ([@b11-etm-0-0-7977],[@b12-etm-0-0-7977]). Other studies have manifested that IL-10 also exerts a vital effect in the intestinal inflammation ([@b13-etm-0-0-7977]). The intestinal mucosal inflammation affects the intestinal nervous system and causes abnormal smooth muscle contraction and sensitivity in the patients, thus leading to abdominal pain, abdominal distension and changes in bowel habits. Patients with these symptoms for more than 2 weeks can be diagnosed with chronic diarrhea.

Furthermore, the occurrence of depression also has relationships to dysfunction of the central NE, 5-HT and BDNF ([@b14-etm-0-0-7977]--[@b16-etm-0-0-7977]). Research results of Karege *et al* ([@b17-etm-0-0-7977]) and Shimizu *et al* ([@b18-etm-0-0-7977]) revealed that compared with those in the normal population, the levels of BDNF and 5-HT in patients with depression are decreased, while the expression level of NE is higher than the normal value. After the drug treatment, the levels of BDNF and 5-HT in serum of patients with improved depression symptoms return to normal, but the level of NE level declines, indicating that changes in the levels of BDNF, 5-HT and NE may be associated with depression in patients ([@b18-etm-0-0-7977],[@b19-etm-0-0-7977]). The treatment for depression has achieved good results, but since drug treatment brings a variety of side effects to patients, such as xerostomia, constipation, palpitation and dizziness and the patients need to take drugs for a long time, the medication compliance is poor. Electroacupuncture treatment for depression was implemented in the 20th century with good results ([@b19-etm-0-0-7977],[@b20-etm-0-0-7977]). This study investigated the efficacy of electroacupuncture combined with probiotics for patients with depression and chronic diarrhea, so as to provide a new idea for the improvement of the patients\' traditional treatment regimens.

The results of this study demonstrated that there was no significant difference in the total HAM-D score between the control group and the observation group, but the improvement degrees of sleep disorders and cognitive impairment in the former were better than that in the latter (p\<0.05). After treatment, the cytokine levels in the two groups of patients were markedly decreased, and there was no statistical difference between the two groups (p\>0.05). The NE level in patients of the observation group was not significantly different from that in patients of the control group, but the change degrees of 5-HT and BDNF in the observation group were higher than those in the control group (p\<0.05). Moreover, the change degree of intestinal flora imbalance and the treatment effective rate in the observation group were higher than those in the control group. The above results indicate that electroacupuncture combined with probiotics is superior to traditional drug therapy in the treatment of patients with depression and chronic diarrhea, and this method is worthy of further promotion in clinical practice.
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###### 

Comparison of the HAM-D score between the two groups of patients (mean ± SD).

                         Observation group (n=56)   Control group (n=48)                
  ---------------------- -------------------------- ---------------------- ------------ ---------------------------------------------------------
  Total score of HAM-D   32.34±5.43                 15.57±3.79             29.34±6.09   14.34±4.65
  Weight                 2.47±1.08                  0.89±0.47              1.97±2.16    1.03±0.66
  Sleep disorder         5.42±2.13                  1.45±1.34              5.86±3.18    2.95±2.13^[a](#tfn1-etm-0-0-7977){ref-type="table-fn"}^
  Anxiety/somatization   6.36±4.24                  4.21±1.93              5.96±4.67    3.84±1.82
  Day and night change   1.72±0.86                  0.85±0.47              1.57±0.67    0.99±0.83
  Retardant              7.48±3.54                  4.16±2.35              6.95±2.64    4.67±3.12
  Feeling of despair     5.36±2.37                  3.58±1.83              4.97±1.86    3.74±2.11
  Cognitive disorder     6.84±3.83                  3.68±2.85              7.46±2.93    5.17±2.04^[a](#tfn1-etm-0-0-7977){ref-type="table-fn"}^

P\<0.05 vs. control group after treatment. HAM-D, Hamilton Depression Rating Scale; SD, standard deviation.

###### 

Comparison of the intestinal flora between the two groups of patients (Ig CFU/g, mean ± SD).

                           Observation group (n=56)   Control group (n=48)                
  ------------------------ -------------------------- ---------------------- ------------ ----------------------------------------------------------
  Enterobacterium          13.94±2.83                 7.54±2.36              14.25±3.04   8.13±3.62
  *Enterococcus*           10.68±2.37                 7.31±3.17              11.53±3.64   9.64±3.58
  *Bacteroides fragilis*   10.78±6.35                 10.39±3.22             11.23±7.26   11.02±3.15^[a](#tfn2-etm-0-0-7977){ref-type="table-fn"}^
  *Lactobacillus*          6.67±1.36                  9.63±1.37              6.96±1.21    9.52±3.04
  *Bifidobacterium*        9.62±0.95                  10.04±1.05             8.43±1.03    9.56±1.85

P\<0.05 vs. control group after treatment. SD, standard deviation.

###### 

Comparison of the levels of NE and 5-HT before and after treatment between the two groups of patients.

                 Observation group (n=56)   Control group (n=48)                                                       
  -------------- -------------------------- ------------------------------------------------------------ ------------- --------------
  NE (ng/ml)     0.86±0.57                  0.59±0.23^[a](#tfn3-etm-0-0-7977){ref-type="table-fn"}^      0.92±0.63     0.67±0.31
  5-HT (ng/ml)   79.58±43.54                154.38±59.62^[a](#tfn3-etm-0-0-7977){ref-type="table-fn"}^   82.43±39.84   138.56±61.37

P\<0.05 vs. control group after treatment. NE, norepinephrine; 5-HT, 5-hydroxytryptamine.

###### 

Comparison of the efficacy of chronic diarrhea between the two groups of patients \[n (%)\].

  Groups               Markedly effective   Effective   Ineffective   Total effective rate
  -------------------- -------------------- ----------- ------------- ------------------------------------------------------
  Observation (n=56)   32                   21          3             94.64%^[a](#tfn4-etm-0-0-7977){ref-type="table-fn"}^
  Control (n=48)       23                   18          7             85.42%

P\<0.05 vs. control group after treatment.
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